The DOI matches its Crossref record; 479 of the 479 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Open accessAbstract
Summary The natural history of cirrhosis is characterised by an asymptomatic compensated phase followed by a decompensated phase, marked by the development of overt clinical signs, the most frequent of which are ascites, bleeding, encephalopathy, and jaundice. The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis. In this context, the panel of experts, having emphasised the importance of initiating aetiologic treatment for any degree of hepatic disease at the earliest possible stage, extended its work to all the complications of cirrhosis, which had not been covered by the European Association for the Study of the Liver guidelines, namely: ascites, refractory ascites, hyponatremia, gastrointestinal bleeding, bacterial infections, acute kidney injury, hepatorenal syndrome, acute-on-chronic liver failure, relative adrenal failure, cirrhotic cardiomyopathy, hepatopulmonary syndrome, and porto-pulmonary hypertension. The panel of experts, produced these GPGs using evidence from PubMed and Cochrane database searches providing up to date guidance on the management of decompensated cirrhosis with the only purpose of improving clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–479 of 479
Shalimar, Saraswat, V. A., Singh, S. P., Duseja, A. K., Shukla, A., Eapen, C. E., Kumar, D., Pande, G., Venkataraman, J., Puri, P., et al. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13340 · Cited by 68
Loomba, R. S., WESLEY, R. A., Bain, A. J., Csákó, G., & Pucino, F. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.12.018 · Cited by 66
Elia, C., Graupera, I., Barreto, R., Solà, E., Moreira, R., Huelin, P., Ariza, X., Solé, C., Pose, E., Baiges, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.004 · Cited by 66
Worlicek, M., Knebel, K., Linde, H. ‐., Moleda, L., Schölmerich, J., Straub, R. H., & Wiest, R. (2010) · Gut · doi:10.1136/gut.2009.185413 · Cited by 66
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
Kim, T. Y., Song, D. S., Kim, H. Y., Sinn, D. H., Yoon, E. L., Kim, C. W., Jung, Y. K., Suk, K. T., Lee, S. S., Lee, C. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146745 · Cited by 66
MELD Exceptions for Portopulmonary Hypertension: Current Policy and Future Implementation
Goldberg, D. S., Batra, S., Sahay, S., Kawut, S. M., & Fallon, M. B. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12783 · Cited by 64
Cartin‐Ceba, R., & Krowka, M. J. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.01.004 · Cited by 64
Renal function impairment induced by change in posture in patients with cirrhosis and ascites.
Bernardi, M., Santini, C., Trevisani, F., et al. (1985) · Gut · doi:10.1136/gut.26.6.629 · Cited by 62
Self-citationSarwar, A., Zhou, L., Novack, V., et al. (2017) · Hepatology · doi:10.1002/hep.29354 · Cited by 61
Rodríguez, E., Pereira, G., Solà, E., Elia, C., Barreto, R., Pose, E., Colmenero, J., Fernández, J., Navasa, M., Arroyo, V., et al. (2015) · Liver Transplantation · doi:10.1002/lt.24210 · Cited by 60
Diagnosis and treatment of acute renal failure in patients with cirrhosis
Moreau, R., & Lebrec, D. (2007) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.10.004 · Cited by 60
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis
Karagiannakis, D. S., Vlachogiannakos, J., Anastasiadis, G., Vafiadis-Zouboulis, I., & Ladas, S. D. (2014) · Hepatology International · doi:10.1007/s12072-014-9544-6 · Cited by 59
Terg, R., Llano, K., Cobas, S. M., Brotto, C., Barrios, A., Levi, D., Vasen, W., & Bartellini, M. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80062-7 · Cited by 59
Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis
Kim, G., Huh, J. H., Lee, K. J., Kim, M. Y., Shim, K. Y., & Baik, S. K. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4471-8 · Cited by 59
Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
Stirnimann, G., Berg, T., Spahr, L., Zeuzem, S., McPherson, S., Lammert, F., Storni, F., Banz, V. M., Babatz, J., Vargas, V., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14331 · Cited by 58
Bernardi, M., Servadei, D., Trevisani, F., et al. (2009) · Digestion · doi:10.1159/000199198 · Cited by 56
Self-citationThe Perioperative Management of Portopulmonary Hypertension with Nitric Oxide and Epoprostenol
Ramsay, M. A. E., Spikes, C., East, C. A., Lynch, K., Hein, T. H. A., Ramsay, K. J., & Klintmalm, G. B. (1999) · Anesthesiology · doi:10.1097/00000542-199901000-00036 · Cited by 56
Pieper, C. C., Jansen, C., Meyer, C. H., Nadal, J., Lehmann, J., Schild, H. H., Trebicka, J., & Thomas, D. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2016.06.023 · Cited by 56
Self-citationFluid Resuscitation in Acute Illness — Time to Reappraise the Basics
Myburgh, J. (2011) · New England Journal of Medicine · doi:10.1056/nejme1105490 · Cited by 55
Wannhoff, A., Hippchen, T., Weiss, C., Friedrich, K., Rupp, C., Neumann‐Haefelin, C., Dollinger, M., Antoni, C., Stampfl, U., Schemmer, P., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13569 · Cited by 55
Cardiovascular predictors of death in patients with cirrhosis
Cesari, M., Frigo, A. C., Tonon, M., & Angeli, P. (2017) · Hepatology · doi:10.1002/hep.29520 · Cited by 55
Self-citationRaevens, S., Pauw, M. D., Reyntjens, K. M. E. M., Geerts, A. M., Verhelst, X., Berrevoet, F. C., Rogiers, X., TROISI, R. I., Vlierberghe, H. V., & Colle, I. O. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835c504b · Cited by 54
von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis
Horvatits, T., Drolz, A., Roedl, K., Herkner, H., Ferlitsch, A., Perkmann, T., Müller, C. J., Trauner, M. A., Schenk, P., & Fuhrmann, V. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.025 · Cited by 53
Bruns, T., Reuken, P. A., Stengel, S., Gerber, L., Appenrodt, B., Schade, J. H., Lammert, F., Zeuzem, S., & Stallmach, A. (2016) · Liver International · doi:10.1111/liv.13095 · Cited by 52
Zhang, J., Yang, W., Hu, B., Wu, W., & Fallon, M. B. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.027 · Cited by 51
Fede, G., Spadaro, L., Tomaselli, T., Privitera, G., Scicali, R., Vasianopoulou, P., Thalassinos, E., Martin, N., Thomas, M., Purrello, F., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.08.028 · Cited by 51
Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis
Gravito‐Soares, M., Gravito‐Soares, E., Lopes, S., Ribeiro, G., & Figueiredo, P. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000927 · Cited by 50
Gülberg, V., Liss, I., Bilzer, M., et al. (2002) · Digestion · doi:10.1159/000065593 · Cited by 49
Gerbes, A. L., Bertheau-Reitha, U., Falkner, C., et al. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80217-x · Cited by 48
Voiosu, A. M., Daha, I. C., Voiosu, T. A., Mateescu, B. R., Dan, G. A., Băicuş, C., Voiosu, M. R., & Diculescu, M. (2015) · Liver International · doi:10.1111/liv.12866 · Cited by 48
Pande, C., Kumar, A., & Sarin, S. K. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283537d61 · Cited by 47
Reynolds, T. B., Lieberman, F. L., & Goodman, A. (1978) · Gut · doi:10.1136/gut.19.6.549 · Cited by 47
Gadano, A. C., Moreau, R., Vachiéry, F., Soupison, T., Yang, S., Cailmail, S., Sogni, P., Hadengue, A., Durand, F., Valla, D. C., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80456-4 · Cited by 47
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease
O’Leary, J. G., & Davis, G. L. (2009) · Liver Transplantation · doi:10.1002/lt.21836 · Cited by 47
The clinical course of cirrhosis. Population based studies and the need of personalized medicine
D’Amico, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.023 · Cited by 46
Nuclear factor‐κB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy
Liu, H., & Lee, S. S. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01692.x · Cited by 46
Solà, E., Sánchez-Cabús, S., Rodríguez, E., Elia, C., Cela, R., Moreira, R., Pose, E., Sánchez‐Delgado, J., Cañete, N., Morales‐Ruiz, M., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24763 · Cited by 46
de Cleva, R., da Silva, F. P., Zilberstein, B., et al. (2001) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812001000400006 · Cited by 45
Merli, M., Torromeo, C., Giusto, M., Iacovone, G., Riggio, O., & Puddu, P. E. (2016) · Liver International · doi:10.1111/liv.13287 · Cited by 45
Rosi, S., Piano, S. S., Frigo, A. C., Morando, F., Fasolato, S., Cavallin, M., Gola, E., Romano, A., Montagnese, S., Sticca, A., et al. (2015) · Liver International · doi:10.1111/liv.12852 · Cited by 44
Self-citationAwdish, R., & Cajigas, H. R. (2013) · Lung · doi:10.1007/s00408-013-9501-5 · Cited by 43
Chen, R. P., Ge, X. J. Z., Huang, Z. M., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a115e9 · Cited by 42
Elfert, A. A., Ali, L. A., Soliman, S. M., et al. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000714 · Cited by 42
Guardiola, J., Baliellas, C., Xiol, X., Fernández‐Esparrach, G., Ginès, P., Ventura, P. J., & Vazquez, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05928.x · Cited by 41
Sampaio, F., Pimenta, J. M., Bettencourt, N., Fontes‐Carvalho, R., Silva, A.-P., Valente, J. P. P., Bettencourt, P., Fraga, J., & Gama, V. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.01.011 · Cited by 41
Jang, J. Y., Kim, T., Sohn, J. H., Lee, T. H., Jeong, S. W., Park, E. J., Lee, S. H., Kim, S. G., Kim, Y. S., Kim, H. S., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12891 · Cited by 40
Effect of dipyridamole on kidney function in cirrhosis,
Llach, J. (1993) · Hepatology · doi:10.1016/0270-9139(93)90192-p · Cited by 40
Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters
Madsen, B. S., Nielsen, K. F., Fialla, A. D., & Krag, A. A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.031 · Cited by 39
Self-citationAcute-on-chronic Liver Failure
Sarin, S. K., & Choudhury, A. K. (2016) · Current Gastroenterology Reports · doi:10.1007/s11894-016-0535-8 · Cited by 39
Pose, E., Solà, E., Piano, S. S., Gola, E., Graupera, I., Guevara, M., Cárdenas, A., Angeli, P., & Ginès, P. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.011 · Cited by 39
Self-citationMaleux, G. A., PEREZ-GUTIERREZ, N., Évrard, S., Mroue, A. G., Moine, O. L., Laleman, W., & Nevens, F. (2010) · PubMed · Cited by 38
Self-citationPiano, S. S., Morando, F., Carretta, G., Tonon, M., Vettore, E., Rosi, S., Stanco, M., Pilutti, C., Romano, A., Brocca, A., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.253 · Cited by 36
Self-citationUF-1000i: validation of the body fluid mode for counting cells in body fluids
Fleming, C., Brouwer, R., van Alphen, A. M., et al. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0512 · Cited by 35
Gaskari, S. A., Liu, H., D’Mello, C., Kunos, G., & Lee, S. S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.021 · Cited by 34
Bruns, T., Lutz, P. L., Stallmach, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.040 · Cited by 34
Busk, T. M., Bendtsen, F., Henriksen, J. H., Fuglsang, S., Clemmesen, J. O., Larsen, F. S., & Møller, S. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.06.011 · Cited by 33
Zhang, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4745 · Cited by 32
Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure
Allen, A. M., & Kim, W. R. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1583201 · Cited by 28
Hanafy, A. S., & Hassaneen, A. M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000743 · Cited by 28
What’s new in the treatment of portopulmonary hypertension?
DuBrock, H. M., Channick, R. N., & Krowka, M. J. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1035647 · Cited by 27
Endovascular Management of Gastric Varices
Saad, W. E. A. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.07.005 · Cited by 27
Preventing the Progression of AKI to CKD: The Role of Mitochondria
de Seigneux, S., & Martin, P. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020146 · Cited by 26
A new flow cytometric method for differential cell counting in ascitic fluid
van de Geijn, G. M., van Gent, M., van Pul‐Bom, N., et al. (2014) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21171 · Cited by 25
Lin, B., Pan, C. Q., Xie, D., Xie, J., Xie, S.-B., Zhang, X., Wu, B., Lin, C., & Gao, Z. (2013) · Hepatology International · doi:10.1007/s12072-012-9415-y · Cited by 25
Barth, F., Gerber, P., Reichen, J., Dufour, J., & Nicod, L. P. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000231749.60889.f7 · Cited by 23
Vaptans and the Treatment of Water-Retaining Disorders
Quittnat, F., & Gross, P. A. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.02.003 · Cited by 22
Zeng, J., Chen, L., Chen, B., Lu, K., Belguise, K., Wang, X., & Yi, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430252 · Cited by 22
Rai, N., Singh, B., Singh, A. K., Vijayvergiya, R., Sharma, N., Bhalla, A., & Singh, V. (2016) · Liver International · doi:10.1111/liv.13250 · Cited by 22
Tsai, M.-H., Huang, H., Peng, Y.-S., Chen, Y., Tian, Y., Yang, C., Lien, J., Fang, J., Wu, C., & Lee, F. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000544 · Cited by 20
Cardiac dysfunction in patients with cirrhosis
Cesari, M., Fasolato, S., Rosi, S., & Angeli, P. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000340 · Cited by 17
Self-citationKrag, A. A., Bendtsen, F., Dahl, E., Kjær, A., Petersen, C. L., & Møller, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109179 · Cited by 17
Self-citationCholongitas, Ε., Goulis, I., Pagkalidou, E., Haidich, A., Karagiannis, A., Nakouti, T., Pipili, C., Oikonomou, T., Gerou, S., & Akriviadis, E. A. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.0298 · Cited by 15
Shaikh, S. A., Tischer, S. M., Choi, E. K., & Fontana, R. J. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12558 · Cited by 14
Walters, J. R. F. (2007) · Gut · doi:10.1136/gut.2006.107847 · Cited by 12
Portopulmonary hypertension: Formidable dual threat versus hopeful dual therapy
Krowka, M. J., & Cartin‐Ceba, R. (2014) · Liver Transplantation · doi:10.1002/lt.23885 · Cited by 11
Piano, S. S., Schmidt, H., Ariza, X., Amorós, A., Romano, A., Solà, E., Gerbes, A., Bernardi, M., Alessandria, C., Trebicka, J., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31564-7 · Cited by 7
Self-citationXiang-Hui, Y., Xiao, L., Yan, Z., Li, Z., Xiao-feng, S., & Hong, R. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.10.007 · Cited by 6
Fernández, J., Acevedo, J., & Arroyo, V. (2017) · Liver International · doi:10.1111/liv.13283 · Cited by 6
Piano, S. S., & Angeli, P. (2016) · Hepatology · doi:10.1002/hep.28443 · Cited by 4
Self-citation
Research works printed but not linked: 130
- Arroyo, 2007, Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome, J Hepatol, 46, 935, 10.1016/j.jhep.2007.02.001 · doi:10.1016/j.jhep.2007.02.001
- Alvarez, 2011, Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients, J Clin Gastroenterol, 45, 906, 10.1097/MCG.0b013e3182284e13 · DOI
- Moreau, 2017, A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis, J Hepatol, 66, S1, 10.1016/S0168-8278(17)30264-7 · doi:10.1016/s0168-8278(17)30264-7
- Sola, 2017, Midodrine and albumin for prevention of complications of cirrhosis in patients in the waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial, J Hepatol, 66, S11, 10.1016/S0168-8278(17)30285-4 · doi:10.1016/s0168-8278(17)30285-4
- Gerbes, 1991, Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence, Cancer, 68, 1808, 10.1002/1097-0142(19911015)68:8<1808::AID-CNCR2820680827>3.0.CO;2-6 · doi:10.1002/1097-0142(19911015)68:8<1808::aid-cncr2820680827>3.0.co;2-6
- Biselli, 2015, A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18, Liver Int, 35, 184, 10.1111/liv.12538 · doi:10.1111/liv.12538
- Lin, 2005, Should bleeding tendency deter abdominal paracentesis?, Dig Liver Dis, 37, 946, 10.1016/j.dld.2005.07.009 · doi:10.1016/j.dld.2005.07.009
- Cabrera, 1982, Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage, Gastroenterology, 82, 97, 10.1016/0016-5085(82)90129-9 · doi:10.1016/0016-5085(82)90129-9
- Guevara, 2004, Effects of contrast media on renal function in patients with cirrhosis: a prospective study, Hepatology, 40, 646, 10.1002/hep.20373 · doi:10.1002/hep.20373
- Saab, 2006, TIPS vs. paracentesis for cirrhotic patients with refractory ascites, Cochrane Database Syst Rev, CD004889
- Gaba, 2015, Survival benefit of TIPS vs. serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis, Clin Radiol, 70, e51, 10.1016/j.crad.2015.02.002 · DOI
- Lenaerts, 2006, Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system, Hepatology, 44, 844, 10.1002/hep.21355 · doi:10.1002/hep.21355
- Singh, 2013, Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study, Am J Gastroenterol, 108, 560, 10.1038/ajg.2013.9 · doi:10.1038/ajg.2013.9
- Tandon, 2009, The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study, Liver Int, 29, 169, 10.1111/j.1478-3231.2008.01778.x · doi:10.1111/j.1478-3231.2008.01778.x
- Badillo, 2014, Hepatic hydrothorax. Clinical features, management, and outcomes in 77 patients and review of the literature, Medicine, 93, 135, 10.1097/MD.0000000000000025 · doi:10.1097/md.0000000000000025
- Garbuzenko, 2017, Hepatic hydrothorax: An update and review of the literature, World J Hepatol, 1197, 10.4254/wjh.v9.i31.1197 · doi:10.4254/wjh.v9.i31.1197
- Zenda, 1998, Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging, Am J Gastroenterol, 9, 2288, 10.1111/j.1572-0241.1998.00639.x · doi:10.1111/j.1572-0241.1998.00639.x
- Hewett, 2016, Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy, Hepatology, 64, 1364, 10.1002/hep.28634 · doi:10.1002/hep.28634
- Alonso, 2010, Pleural effusion in liver disease, Semin Respir Crit Care Med, 31, 698, 10.1055/s-0030-1269829 · doi:10.1055/s-0030-1269829
- Xiol, 2005, Liver transplantation in patients with hepatic hydrothorax, Transpl Int, 18, 672, 10.1111/j.1432-2277.2005.00116.x · doi:10.1111/j.1432-2277.2005.00116.x
- Sersté, 2010, The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation, Eur J Gastroenterol Hepatol, 22, 207, 10.1097/MEG.0b013e3283311140 · doi:10.1097/meg.0b013e3283311140
- Hou, 2016, Effectiveness and safety of pleurodesis for hepatic hydrothorax: A systematic review and meta-analysis, Dig Dis Sci, 61, 3321, 10.1007/s10620-016-4260-9 · doi:10.1007/s10620-016-4260-9
- Huang, 2016, Thoracoscopic mesh repair of diaphragmatic defects in hepatic hydrothorax: A 10-year experience, Ann Thorac Surg, 101, 1921, 10.1016/j.athoracsur.2015.11.023 · doi:10.1016/j.athoracsur.2015.11.023
- Cordoba, 2010, Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence, Metab Brain Dis, 25, 73, 10.1007/s11011-010-9172-3 · DOI
- Garcia-Pagan, 2008, Review article: the modern management of portal hypertension–primary and secondary prophylaxis of variceal bleeding in cirrhotic patients, Aliment Pharmacol Ther, 28, 178, 10.1111/j.1365-2036.2008.03729.x · doi:10.1111/j.1365-2036.2008.03729.x
- Li, 2016, Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis, BMJ Open, 6, e010902, 10.1136/bmjopen-2015-010902 · doi:10.1136/bmjopen-2015-010902
- Payance, 2016, Lack of clinical or haemodynamic rebound after abrupt interruption of beta-blockers in patients with cirrhosis, Aliment Pharmacol Ther, 43, 966, 10.1111/apt.13577 · doi:10.1111/apt.13577
- Villanueva, 2014, Optimizing general management of acute variceal bleeding in cirrhosis, Curr Hepatol Rep, 13, 198, 10.1007/s11901-014-0241-7 · doi:10.1007/s11901-014-0241-7
- Avgerinos, 1997, Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial, Lancet, 350, 1495, 10.1016/S0140-6736(97)05099-X · doi:10.1016/s0140-6736(97)05099-x
- Azam, 2012, Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial, J Hepatol, 56, 819, 10.1016/j.jhep.2011.11.019 · doi:10.1016/j.jhep.2011.11.019
- Rios Castellanos, 2015, Endoscopic injection of cyanoacrylate glue vs. other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension, Cochrane Database Syst Rev, 5, CD010180
- Thuluvath, 2002, Portal Hypertensive gastropathy, Am J Gastroenterol, 97, 2973, 10.1111/j.1572-0241.2002.07094.x · doi:10.1111/j.1572-0241.2002.07094.x
- Yoshikawa, 1998, Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow, Am J Gastroenterol, 93, 71, 10.1111/j.1572-0241.1998.071_c.x · doi:10.1111/j.1572-0241.1998.071_c.x
- Urrunaga, 2014, Portal hypertensive gastropathy and colopathy, Clin Liver Dis, 18, 389, 10.1016/j.cld.2014.01.008 · doi:10.1016/j.cld.2014.01.008
- Hosking, 1987, The role of propranolol in congestive gastropathy of portal hypertension, Hepatology, 7, 437, 10.1002/hep.1840070304 · doi:10.1002/hep.1840070304
- Ripoll, 2007, Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension, Curr Treat Options Gastroenterol, 10, 483, 10.1007/s11938-007-0048-5 · doi:10.1007/s11938-007-0048-5
- Kamath, 2000, Gastric Mucosal Responses to intrahepatic portosystemic shunting in patients with cirrhosis, Gastroenterology, 118, 905, 10.1016/S0016-5085(00)70176-4 · doi:10.1016/s0016-5085(00)70176-4
- Rios, 2015, Endoscopic injection of cyanoacrylate glue vs. other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension, Cochrane Database Syst Rev, 5, CD010180
- Runyon, 2003, The evolution of ascitic fluid analysis in the diagnosis of spontaneous bacterial peritonitis. Runyon BA, Am J Gastroenterol, 98, 1675, 10.1111/j.1572-0241.2003.07600.x · doi:10.1111/j.1572-0241.2003.07600.x
- Gülberg, 2007, Insufficient sensitivity of reagent strips for spontaneous bacterial peritonitis, Hepatology, 46, 1669, 10.1002/hep.21856 · doi:10.1002/hep.21856
- Chen, 2011, Outcome predictors of cirrhotic patients with spontaneous bacterial empyema, Liver Int, 31, 417, 10.1111/j.1478-3231.2010.02447.x · doi:10.1111/j.1478-3231.2010.02447.x
- Garioud, 2017, J Clin Gastroenterol, 51, 831, 10.1097/MCG.0000000000000735 · doi:10.1097/mcg.0000000000000735
- Krag, 2010, Fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis, Am J Gastroenterol, 105, 1444, 10.1038/ajg.2010.126 · doi:10.1038/ajg.2010.126
- Arvaniti, 2010, Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis, Gastroenterology, 139, 1256, 10.1053/j.gastro.2010.06.019 · DOI · Paper page
- Fiore, 2017, Risk of spontaneousfungalperitonitis in hospitalized cirrhotic patients with ascites: a systematic review of observational studies and meta-analysis, Minerva Anestesiol, 83, 1309, 10.23736/S0375-9393.17.12034-1 · doi:10.23736/s0375-9393.17.12034-1
- Piano, 2017, Why and how to measure renal function in patients with liver disease, Liver Int, 37, 116, 10.1111/liv.13305 · doi:10.1111/liv.13305
- Roy, 1998, Glomerular filtration rate measurement in cirrhotic patients with renal failure, Clin Nephrol, 50, 342
- de Carvalho, 2012, Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites, J Clin Gastroenterol, 46, 21, 10.1097/MCG.0b013e31822e8e12 · doi:10.1097/mcg.0b013e31822e8e12
- 2012, Clinical practice guideline for the evaluation and management of chronic kidney disease, Kidny Int, 2013, 1
- Guevara, 2004, Effects of contrast media on renal function in patients with cirrhosis: a prospective study, Hepatology, 40, 646, 10.1002/hep.20373 · doi:10.1002/hep.20373
- Umgelter, 2009, Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites, Intensive Care Med, 35, 152, 10.1007/s00134-008-1253-y · doi:10.1007/s00134-008-1253-y
- Umgelter, 2008, Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial, Critical care, 12, R4, 10.1186/cc6765 · doi:10.1186/cc6765
- Qasem, 2014, Urinary biomarkers of acute kidney injury in patients with liver cirrhosis, ISRN Nephrol, 2014, 376795, 10.1155/2014/376795 · doi:10.1155/2014/376795
- Huelin, 2017, New diagnostic algorithm of acute kidney injury in cirrhosis that includes categorization of stage 1 and assessment of urine NGAL. Relevance for the differential diagnosis and clinical outcomes, J Hepatol, 66, S11, 10.1016/S0168-8278(17)30283-0 · doi:10.1016/s0168-8278(17)30283-0
- Wadei, 2008, Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy, Am J Transplant, 8, 2618, 10.1111/j.1600-6143.2008.02426.x · doi:10.1111/j.1600-6143.2008.02426.x
- Bairaktari, 2001, Partially reversible renal tubular damage in patients with obstructive jaundice, Hepatology, 33, 1365, 10.1053/jhep.2001.25089 · doi:10.1053/jhep.2001.25089
- van Slambrouck, 2013, Bile cast nephropathy is a common pathologic finding fo kidney injury associated with severe liver dysfunction, Kidney Int, 84, 192, 10.1038/ki.2013.78 · doi:10.1038/ki.2013.78
- Moreau, 2002, Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study, Gastroenterology, 122, 923, 10.1053/gast.2002.32364 · doi:10.1053/gast.2002.32364
- Gerbes, 2009, Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration, Gastroenterology, 137, 1179, 10.1053/j.gastro.2009.03.064 · doi:10.1053/j.gastro.2009.03.064
- Piano, 2011, Continuousrecurrenceof type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?, J Hepatol, 55, 491, 10.1016/j.jhep.2011.02.002 · doi:10.1016/j.jhep.2011.02.002
- Gow, 2016, Outpatient terlipressin infusion for the treatment of refractory ascites, Am J Gastroenterol, 111, 1041, 10.1038/ajg.2016.168 · doi:10.1038/ajg.2016.168
- Duvoux, 2002, Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study, Hepatology, 36, 374, 10.1053/jhep.2002.34343 · doi:10.1053/jhep.2002.34343
- Esrailian, 2007, Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome, Dig Dis Sci, 52, 742, 10.1007/s10620-006-9312-0 · doi:10.1007/s10620-006-9312-0
- Brensing, 2000, Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study, Gut, 47, 288, 10.1136/gut.47.2.288 · doi:10.1136/gut.47.2.288
- Testino, 2003, Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation, Hepatogastroenterology, 50, 1753
- Sourianarayanane, 2014, Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients, Int Urol Nephrol, 46, 793, 10.1007/s11255-013-0527-7 · doi:10.1007/s11255-013-0527-7
- Trebicka, 2016, Predisposing factors in acute-on-chronic liver failure, Semin Liver Dis, 36, 167, 10.1055/s-0036-1583195 · doi:10.1055/s-0036-1583195
- Silva, 2015, Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis, Liver Int, 35, 1516, 10.1111/liv.12597 · doi:10.1111/liv.12597
- Lee, 2015, CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis, Liver Int, 35, 46, 10.1111/liv.12683 · DOI
- Chen, 2014, Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure, J Gastroenterol Hepatol, 29, 800, 10.1111/jgh.12454 · doi:10.1111/jgh.12454
- Guo, 2016, Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial, Chin J Integr Med, 22, 573, 10.1007/s11655-016-2582-2 · doi:10.1007/s11655-016-2582-2
- De, 2003, Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis, J Hepatol, 39, 315, 10.1016/S0168-8278(03)00271-X · doi:10.1016/s0168-8278(03)00271-x
- Grose, 1995, Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis, J Hepatol, 22, 326, 10.1016/0168-8278(95)80286-X · doi:10.1016/0168-8278(95)80286-x
- Kim, 2010, Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis, Korean J Hepatol, 16, 376, 10.3350/kjhep.2010.16.4.376 · doi:10.3350/kjhep.2010.16.4.376
- Kozor, 2016, Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping, Eur Heart J Cardiovasc Imaging, 18, 1034, 10.1093/ehjci/jew187 · doi:10.1093/ehjci/jew187
- Ngu, 2016, Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease, Int J Cardiovasc Imaging, 32, 629, 10.1007/s10554-015-0824-6 · doi:10.1007/s10554-015-0824-6
- Trevisani, 2012, QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis, Liver Int, 32, 1510, 10.1111/j.1478-3231.2012.02847.x · doi:10.1111/j.1478-3231.2012.02847.x
- Zhao, 2016, Prevalence, risk factors and in-hospital outcomes of QTc interval prolongation in liver cirrhosis, Am J Med Sci, 352, 285, 10.1016/j.amjms.2016.06.012 · doi:10.1016/j.amjms.2016.06.012
- Raevens, 2014, Prevalence and outcome of diastolic dysfunction in liver transplantation recipients, Acta Cardiol, 69, 273, 10.1080/AC.69.3.3027830 · doi:10.1080/ac.69.3.3027830
- Saner, 2011, High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients, Transpl Int, 24, 425, 10.1111/j.1432-2277.2011.01219.x · doi:10.1111/j.1432-2277.2011.01219.x
- Alexopoulou, 2012, Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis, Transpl Int, 25, 1174, 10.1111/j.1432-2277.2012.01547.x · doi:10.1111/j.1432-2277.2012.01547.x
- Machicao, 2014, Pulmonary complications in chronic liver disease, Hepatology, 59, 1627, 10.1002/hep.26745 · doi:10.1002/hep.26745
- Kaymakoglu, 2003, Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients, Dig Dis Sci, 48, 556, 10.1023/A:1022549018807 · doi:10.1023/a:1022549018807
- Rodríguez-Roisin, 1992, The hepatopulmonary syndrome: new name, old complexities, Thorax, 47, 897, 10.1136/thx.47.11.897 · doi:10.1136/thx.47.11.897
- Fallon, 2000, Pulmonary dysfunction in chronic liver disease, Hepatology, 32, 859, 10.1053/jhep.2000.7519 · doi:10.1053/jhep.2000.7519
- Schraufnagel, 2006, Structural and pathologic changes in the lung vasculature in chronic liver disease, Clin Chest Med, 17, 1, 10.1016/S0272-5231(05)70295-1 · doi:10.1016/s0272-5231(05)70295-1
- Boryczka, 2015, Influence of an upright body position on the size of intrapulmonary blood shunts in patients with advanced liver cirrhosis, J Physiol Pharmacol, 66, 855
- Fallon, 1997, The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome, Gastroenterology, 113, 606, 10.1053/gast.1997.v113.pm9247483 · doi:10.1053/gast.1997.v113.pm9247483
- Luo, 2004, ET-1 and TNF- alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats, Am J Physiol Gastrointest Liver Physiol, 286, G294, 10.1152/ajpgi.00298.2003 · doi:10.1152/ajpgi.00298.2003
- Ling, 2004, The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat, Hepatology, 39, 1593, 10.1002/hep.20244 · doi:10.1002/hep.20244
- Tang, 2007, Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome, Am J Physiol Lung Cell Mol Physiol, 292, L1467, 10.1152/ajplung.00446.2006 · doi:10.1152/ajplung.00446.2006
- Frossard, 2007, Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome, Am J Physiol Gastrointest Liver Physiol, 293, G864, 10.1152/ajpgi.00136.2007 · doi:10.1152/ajpgi.00136.2007
- Chang, 2015, Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung, Clin Sci, 129, 449, 10.1042/CS20140622 · doi:10.1042/cs20140622
- Rodriquez-Roisin, 2005, ERS (European Respiratory Society) Task ForcePHD Scientific Committee. Highlights of the ERS task force on pulmonary-hepatic vascular disorders (PHD), J Hepatol, 42, 924, 10.1016/j.jhep.2005.03.002 · doi:10.1016/j.jhep.2005.03.002
- Hoerning, 2014, Pulse oximetry is insufficient for timely diagnosis of hepatopulmonary syndrome in children with liver cirrhosis, J Pediatr, 164, 546, 10.1016/j.jpeds.2013.10.070 · doi:10.1016/j.jpeds.2013.10.070
- Köksal, 2006, Evaluation of intrapulmonary vascular dilatations with high-resolution computed thorax tomography in patients with hepatopulmonary syndrome, J Clin Gastroenterol, 40, 77, 10.1097/01.mcg.0000190775.57903.86 · doi:10.1097/01.mcg.0000190775.57903.86
- Lee, 1999, Hypoxemia and liver cirrhosis (hepatopulmonary syndrome) in eight patients: comparison of the central and peripheral pulmonary vasculature, Radiology, 211, 549, 10.1148/radiology.211.2.r99ma46549 · doi:10.1148/radiology.211.2.r99ma46549
- Abrams, 1995, Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome, Gastroenterology, 109, 1283, 10.1016/0016-5085(95)90589-8 · doi:10.1016/0016-5085(95)90589-8
- Wolfe, 1977, Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method, Am J Med, 63, 746, 10.1016/0002-9343(77)90161-9 · doi:10.1016/0002-9343(77)90161-9
- Kalambokis, 2010, Pitfalls in the assessment of intrapulmonary shunt using lung perfusion scintigraphy in patients with cirrhosis, Liver Int, 31, 138, 10.1111/j.1478-3231.2010.02330.x · doi:10.1111/j.1478-3231.2010.02330.x
- Kochar, 2011, Serial pulse oximetry in hepatopulmonary syndrome, Dig Dis Sci, 56, 1862, 10.1007/s10620-011-1600-7 · doi:10.1007/s10620-011-1600-7
- Tanikella, 2008, Pilot study of pentoxifylline in hepatopulmonary syndrome, Liver Transpl, 14, 1199, 10.1002/lt.21482 · doi:10.1002/lt.21482
- Gupta, 2008, Pentoxyfylline therapy for hepatopulmonary syndrome: a piloto study, Arch Intern Med, 168, 1820, 10.1001/archinte.168.16.1820 · doi:10.1001/archinte.168.16.1820
- De, 2010, The role of garlic in hepatopulmonary syndrome: a randomized controlled trial, Can J Gastroenterol, 24, 183, 10.1155/2010/349076 · doi:10.1155/2010/349076
- Tsauo, 2015, Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review, J Vasc Interv Radiol, 26, 1266, 10.1016/j.jvir.2015.04.017 · doi:10.1016/j.jvir.2015.04.017
- Poterucha, 1995, Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy, Hepatology, 21, 96, 10.1002/hep.1840210117 · doi:10.1002/hep.1840210117
- Fallon, 2006, Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome, Liver Transpl, 12, S105, 10.1002/lt.20971 · doi:10.1002/lt.20971
- Fleming, 2008, Hepatopulmonary syndrome use of extracorporeal life support for life-threatening hypoxia following liver transplantation, Liver Transpl, 14, 966, 10.1002/lt.21477 · doi:10.1002/lt.21477
- Monsel, 2011, Extracorporeal membrane oxygenation as a brifge to liver trnsplantation for acute respiratory distress syndrome-induced life-threatening hypoxemia aggravated by hepatopulmonary syndrome, Crit Care, 15, R234, 10.1186/cc10476 · doi:10.1186/cc10476
- Chihara, 2011, Immediate nonivasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation, Liver Transpl, 17, 44, 10.1002/lt.22207 · doi:10.1002/lt.22207
- Torregrosa, 2001, Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates, Transplantation, 71, 572, 10.1097/00007890-200102270-00015 · doi:10.1097/00007890-200102270-00015
- Cotton, 2002, Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates, Liver Transpl, 8, 1051, 10.1053/jlts.2002.35554 · doi:10.1053/jlts.2002.35554
- Paulus, 2013, Oestrogen and sexual Dimorphism of pulmonary arterial hypertension; a transitional challenge, Eur Respir J, 41, 1014, 10.1183/09031936.00021713 · doi:10.1183/09031936.00021713
- Condino, 2005, Portopulmonary hypertension in pediatric patients, J Pediatr, 147, 20, 10.1016/j.jpeds.2005.02.019 · doi:10.1016/j.jpeds.2005.02.019
- Ricci, 2007, Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension, Liver Transpl, 13, 1506, 10.1002/lt.21173 · doi:10.1002/lt.21173
- Halank, 2004, Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension, Transplantation, 77, 1775, 10.1097/01.TP.0000122420.86904.89 · doi:10.1097/01.tp.0000122420.86904.89
- Cadden, 2009, The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation, Ann Hepatol, 8, 158, 10.1016/S1665-2681(19)31798-3 · doi:10.1016/s1665-2681(19)31798-3
- Fisher, 2015, Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension, Can Respir J, 22, 42, 10.1155/2015/810376 · doi:10.1155/2015/810376
- Tzathas, 2002, Sildenafil (viagra) is a risk factor for acute variceal bleeding, Am J Gastroenterol, 97, 1856, 10.1111/j.1572-0241.2002.05876.x · doi:10.1111/j.1572-0241.2002.05876.x
- Sussman, 2006, Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series, Am J Transplant, 6, 2177, 10.1111/j.1600-6143.2006.01432.x · doi:10.1111/j.1600-6143.2006.01432.x
- Melgosa, 2010, Acute and long-term effects of inhaled iloprost in portopulmonary hypertension, Liver Transpl, 16, 348, 10.1002/lt.21997 · doi:10.1002/lt.21997
- Colombato, 1996, Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients, Gut, 39, 600, 10.1136/gut.39.4.600 · doi:10.1136/gut.39.4.600
- Yoshida, 1993, Single-lung vs. liver transplantation for the treatment of portopulmonary hypertension–a comparison of two patients, Transplantation, 55, 688
- Mangus, 2013, Mild to moderate pulmonary hypertension in liver transplantation, J Surg Res, 184, 1150, 10.1016/j.jss.2013.04.040 · doi:10.1016/j.jss.2013.04.040
- Ramsay, 1997, Severe pulmonary hypertension in liver transplant candidates, Liver Transpl Surg, 3, 494, 10.1002/lt.500030503 · doi:10.1002/lt.500030503
- Krowka, 2006, Model for end-stage liver disease (MELD) exception for portopulmonary hypertension, Liver Transpl, 12, S114, 10.1002/lt.20975 · doi:10.1002/lt.20975
- Ramsay, 2010, Portopulmonary hypertension and right heart failure in patients with cirrhosis, Curr Opin Anaesthesiol, 23, 145, 10.1097/ACO.0b013e32833725c4 · doi:10.1097/aco.0b013e32833725c4
- Paulsen, 1989, Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation, Anesth Analg, 68, 489, 10.1213/00000539-198904000-00012 · doi:10.1213/00000539-198904000-00012
- Stratta, 2013, Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report, Transplant Proc, 45, 2774, 10.1016/j.transproceed.2013.07.001 · doi:10.1016/j.transproceed.2013.07.001
- Khaderi, 2014, Long-term follow-up of portopulmonary hypertension patients after liver transplantation, Liver Transpl, 20, 724, 10.1002/lt.23870 · doi:10.1002/lt.23870
Cited by
Ginès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Self-citationEASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
Tapper, E. B., & Parikh, N. D. (2018) · BMJ · doi:10.1136/bmj.k2817 · Cited by 856
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
Self-citationManagement of Hepatocellular Carcinoma: A Review
Brown, Z. J., Tsilimigras, D. I., Ruff, S. M., Mohseni, A., Kamel, I. R., Cloyd, J. M., & Pawlik, T. M. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2022.7989 · Cited by 763
Metadata
- Authors
- Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 69
- Issue
- 2
- Pages
- 406-460
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2802906787
- Cited by
- 2,905
- References
- 479
- FWCI
- 132.14
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-11-01)
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.